Laurel Wealth Advisors (California)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$457K Hold
6,121
0.05% 378
2022
Q3
$506K Hold
6,121
0.05% 337
2022
Q2
$582K Sell
6,121
-900
-13% -$93.2K 0.06% 324
2022
Q1
$827K Sell
7,021
-52
-0.7% -$5.83K 0.07% 284
2021
Q4
$916K Buy
7,073
+1,552
+28% +$181K 0.07% 280
2021
Q3
$625K Sell
5,521
-1,544
-22% -$176K 0.11% 203
2021
Q2
$731K Hold
7,065
0.09% 216
2021
Q1
$590K Hold
7,065
0.09% 219
2020
Q4
$645K Buy
7,065
+144
+2% +$11.9K 0.09% 203
2020
Q3
$553K Hold
6,921
0.09% 211
2020
Q2
$479K Hold
6,921
0.09% 224
2020
Q1
$435K Sell
6,921
-300
-4% -$21.6K 0.1% 219
2019
Q4
$562K Buy
7,221
+150
+2% +$11.7K 0.09% 226
2019
Q3
$518K Buy
7,071
+1,281
+22% +$90K 0.09% 239
2019
Q2
$357K Sell
5,790
-1,107
-16% -$66.9K 0.08% 271
2019
Q1
$440K Buy
6,897
+1,485
+27% +$84.7K 0.11% 209
2018
Q4
$276K Buy
5,412
+300
+6% +$15.2K 0.08% 263
2018
Q3
$296K Hold
5,112
0.07% 280
2018
Q2
$248K Hold
5,112
0.07% 305
2018
Q1
$237K Buy
+5,112
New +$222K 0.07% 286

Other funds holding EW

Laurel Wealth Advisors (California)'s EW Position: Q4 2022 in Review

Laurel Wealth Advisors (California) held its Edwards Lifesciences (EW) position steady in Q4 2022 at 6,121 shares worth $457K. The position accounts for 0.05% of the portfolio, ranked #378.

Laurel Wealth Advisors (California) first reported a position in EW in Q1 2018 and has held it in 20 quarters since. The position peaked at $916K in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • Laurel Wealth Advisors (California) held 6,121 shares of Edwards Lifesciences worth $457K as of Q4 2022.
  • Laurel Wealth Advisors (California) left its Edwards Lifesciences share count unchanged in Q4 2022.
  • Edwards Lifesciences made up 0.05% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #378 holding.
  • Laurel Wealth Advisors (California) first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 20 quarters since.
  • Laurel Wealth Advisors (California)'s Edwards Lifesciences position peaked at $916K in Q4 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.